Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from ...
These factors combined present a compelling growth story, leading to the Buy rating. Kratky covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, NeuroPace, and Vericel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback